Synthesis, crystal structure and DNA-binding studies of a Ru(II) complex containing two main ligands

Supramolecular architecture and photophysical and biological properties of ruthenium(ii) polypyridyl complexes

A two-dimensional cyclic hybrid water–chloride anionic network has been structurally characterized in a metal–organic matrix. DNA interactions and the cytotoxicity of ruthenium(ii) complexes have been studied.

Spectral, electrochemical, thermal, DNA binding ability, antioxidant and antibacterial studies of novel Ru(III) Schiff base complexes

Four new air stable low spin Ru(III) complexes of the type [Ru(L(1-4))(H2O)2]Cl have been synthesized, where L=dianion of the tetradentate Schiff base ligands namely N,N'bis(salicylaldehyde)4,5-dimethy-l,2-phenylendiammine (L(1)H2), N,N'bis(salicylaldehyde)4,5-dichloro 1,2-phenylendiammine (L(2)H2), N,N'bis(o-vanillin)4,5-dimethy-1,2-phenylendiammine (L(3)H2) and N,N'bis(o-vanillin)4,5-dichloro-1,2-phenylendiammine (L(4)H2). The complexes have been fully characterized by elemental analysis, infrared spectroscopy, electronic spectroscopy, magnetic susceptibility and electron spin resonance spectroscopy. Elemental analyses and spectroscopic data have been showed that, the stoichiometries of complexes were 1:1 with an octahedral geometry for all the complexes. Thermal analysis measurements indicated that the complexes have good thermal stability. The redox behavior of the complexes has been investigated by the cyclic voltammetric technique. The interaction of these complexes with calf thymus DNA (CT-DNA) was explored by different techniques which revealed that the complexes could bind to CT-DNA through an intercalative mode. Furthermore, the antioxidant activity of the Ru(III) complexes against superoxide and hydroxyl radicals was evaluated by using spectrophotometer methods in vitro. The experiments on antioxidant activity show that the complexes were found to possess potent antioxidant activity. Additionally, as a potential application the antibacterial activity of the complexes was assessed by testing their effect on the growth of various strains of bacteria.

Microwave-Assisted Synthesis of Arene Ruthenium(II) Complex as Apoptosis Inducer of A549 Cells

An arene ruthenium(ii) complex coordinated with 2-(2-chlorophenyl)-1H-imidazo[4,5-f][1,10]phenanthroline, [(η6-C6H6)Ru(o-ClPIP)Cl]Cl (1), has been prepared by using microwave-assisted synthesis technology. The anti-tumour activity of this complex against various tumour cells has been evaluated by MTT assay and the results show that complex 1 exhibits selective inhibitory activity against the growth of human lung adenocarcinoma A549 cells with IC50 = 31.58 μM. Further studies by flow cytometric analysis showed that apoptosis of A549 cells was observed when dealt with complex 1. Furthermore, complex 1 exhibits excellent binding affinity with DNA molecules which was confirmed by spectroscopy methods, as well viscosity and melting point experiments. As a result, the conformation of DNA molecules was disturbed by complex 1.

Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid

A great majority of the Ru complexes currently studied in anticancer research exert their antiproliferative activity, at least partially, through ligand exchange. In recent years, however, coordinatively saturated and substitutionally inert polypyridyl Ru(II) compounds have emerged as potential anticancer drug candidates. In this work, we present the synthesis and detailed characterization of two novel inert Ru(II) complexes, namely, [Ru(bipy)(2)(Cpp-NH-Hex-COOH)](2+) (2) and [Ru(dppz)(2)(CppH)](2+) (3) (bipy = 2,2'-bipyridine; CppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid; Cpp-NH-Hex-COOH = 6-(2-(pyridin-2-yl)pyrimidine-4-carboxamido)hexanoic acid; dppz = dipyrido[3,2-a:2',3'-c]phenazine). 3 is of particular interest as it was found to have IC(50) values comparable to cisplatin, a benchmark standard in the field, on three cancer cell lines and a better activity on one cisplatin-resistant cell line than cisplatin itself. The mechanism of action of 3 was then investigated in detail and it could be demonstrated that, although 3 binds to calf-thymus DNA by intercalation, the biological effects that it induces did not involve a nuclear DNA related mode of action. On the contrary, confocal microscopy colocalization studies in HeLa cells showed that 3 specifically targeted mitochondria. This was further correlated by ruthenium quantification using High-resolution atomic absorption spectrometry. Furthermore, as determined by two independent assays, 3 induced apoptosis at a relatively late stage of treatment. The generation of reactive oxygen species could be excluded as the cause of the observed cytotoxicity. It was demonstrated that the mitochondrial membrane potential in HeLa was impaired by 3 as early as 2 h after its introduction and even more with increasing time.

Studies on synthesis, characterization, and G-quadruplex binding of Ru(II) complexes containing two dppz ligands

In this work, the interaction between the guanine-rich single-strand oligomer AG(3)(T(2)AG(3))(3) quadruplex and two Ru(II) complexes, [Ru(L(1))(dppz)(2)](PF(6))(4) (1) and [Ru(L(2))(dppz)(2)](PF(6))(4) (2) (L(1) = 5,5'-di(1-(trimethylammonio)methyl)-2,2'-dipyridyl cation, L(2) = 5,5'-di(1-(triethylammonio)methyl)-2,2'-dipyridyl cation, dppz = dipyrido[3,2-a:2',3'-c] phenazine), has been studied by UV-Visible, fluorescence, DNA melting, and circular dichroism in K(+) buffer. The two complexes after binding to G-quadruplex have shown different DNA stability and fluorescence enhancement. The results show that both complexes can induce the stabilization of quadruplex DNA. ΔT(m) values of complexes 1 and 2 at [Ru]/[DNA] ratio of 1:1 were 9.4 and 7.0, respectively. Binding stoichiometry along with the quadruplex was investigated through a luminescence-based Job plot. The major inflection points for complexes 1 and 2 were 0.49 and 0.46, respectively. The data were consistent with the binding mode at a [quadruplex]/[complex] ratio of 1:1. In addition, the conformation of G-quadruplex was not changed by the complexes at the high ionic strength of K(+) buffer.